safety and effectiveness of pneumococcal vaccines are major priorities for the ADIP team. As a milestone driven project, the ADIP is a new approach to public-private partnerships for improving global health. The team sets strict project goals, and aligns them with timelines, and budgets. The team's performance will be measured against these objectives by a GAVI oversight board.

"Our approach is a departure from previous vaccine efforts. We will take our scientific data and efficacy results directly to decision-makers in developing countries that have the power to set policy. We will support them in their efforts to establish evidence-based decisions on vaccine introduction," said Mathuram Santosham, MD, MPH, professor with the School's Department of International Health.

The announcement marks the first time that GAVI and The Vaccine Fund will fund vaccine research and development efforts. Since 2000, they have focused primarily on ensuring that today's vaccines are made available to every child, everywhere. An additional $30 million was given to the Program for Appropriate Technology in Health (PATH) to develop and introduce a safe and effective rotavirus vaccine for the developing world.

"Pneumococcal infections threaten tens of millions of children throughout the world. Better vaccines and better access to vaccines could save their lives. The School and its partners are committed to this effort," said Alfred Sommer, MD, MHS, dean of the Johns Hopkins Bloomberg School of Public Health.

'"/>

Contact: Tim Parsons
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
11-Feb-2003

Page: 1 2
Related biology news :

1. White House to honor UNC School of Medicine scientist for early career achievement
2. LSU Vet School receives $9.9 million for infectious disease research
3. Researchers in UGA Vet School discover a mechanism that blocks replication of a retrovirus
4. Dartmouth Medical School awarded $9 million grant for genomics research
5. Research news from Tufts University, Friedman School of Nutrition Science and Policy: February 2004
6. Mount Sinai School of Medicine conducting clinical trials with gene therapy for colorectal cancer
7. Harvard Medical School launches new department to study human biology at the level of whole systems
8. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine
9. Dartmouth Medical School geneticists discover new role for antisense RNA
10. School of public health launches CDC Center for Excellence in Environmental Public Health Tracking
11. Grant from Vetlesen Foundation supports URI Graduate School of Oceanography Climate Research